Patent directory · USPTO A61K / A61P
Patents matching “Corcept Therapeutics Incorporated”
120 pharma patents match "Corcept Therapeutics Incorporated" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 120 pharmaceutical patents matching "Corcept Therapeutics Incorporated" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 11890289
Use of glucocorticoid receptor antagonists in combination with glucocorticoids to treat adrenal insufficiency
granted -
US 11793810
Methods of treating neuroepithelial tumors using selective glucocorticoid receptor modulators
granted -
US 11744837
Use of cortisol in assessment and prophylactic treatment of hypokalemia associated with glucocorticoid receptor modulator treatment of Cushing's syndrome patients
granted -
US 11684612
Therapeutic uses of relacorilant, a heteroaryl-ketone fused azadecalin glucocorticoid receptor modulator
granted -
US 11660295
Glucocorticoid receptor modulators to treat cervical cancer
granted -
US 11648245
Heteroaryl-ketone fused azadecalin glucocorticoid receptor modulators
granted -
US 11642331
Glucocorticoid receptor modulators to treat pancreatic cancer
granted -
US 11610666
Systems and methods of managing treatment of a chronic condition by symptom tracking
granted -
US 11590113
Therapeutic uses of relacorilant, a heteroaryl-ketone fused azadecalin glucocorticoid receptor modulator
granted -
US 11590135
Fatty liver disease treatment using glucocorticoid and mineralocorticoid receptor antagonists
granted -
US 11576907
Heteroaryl-ketone fused azadecalin glucocorticoid receptor modulators
granted -
US 11560379
Octahydro fused azadecalin glucocorticoid receptor modulators
granted -
US 11542238
Pyrimidine cyclohexenyl glucocorticoid receptor modulators
granted -
US 11524013
Treatment of hypercoagulopathy in Cushing's syndrome by administration of glucocorticoid receptor modulators
granted -
US 11464764
Pharmaceutical formulations containing relacorilant, a heteroaryl-ketone fused azadecalin compound
granted -
US 11389432
Methods of treating cancer comprising administration of a glucocorticoid receptor modulator and a cancer chemotherapy agent
granted -
US 11370789
Octahydro fused azadecalin glucocorticoid receptor modulators
granted -
US 11327083
Treatment and differential diagnosis of Cushing's disease and ectopic Cushing's syndrome
granted -
US 11285145
Concomitant administration of glucocorticoid receptor modulator relacorilant and paclitaxel, a dual substrate of CYP2C8 and CYP3A4
granted -
US 11268145
Methods for treating Cushing's syndrome
granted -
US 11234971
Methods of treating cancer comprising administration of a glucocorticoid receptor modulator and a cancer chemotherapy agent
granted -
US 11213526
Methods of treating neuroepithelial tumors using selective glucocorticoid receptor modulators
granted -
US 11202787
Use of ACTH in assessment and prophylactic treatment of hypokalemia associated with glucocorticoid receptor modulator treatment of Cushing's syndrome patients
granted -
US 11202784
Use of glucocorticoid receptor antagonists in combination with glucocorticoids to treat adrenal insufficiency
granted